logo
ResearchBunny Logo
A universal dual mechanism immunotherapy for the treatment of influenza virus infections

Medicine and Health

A universal dual mechanism immunotherapy for the treatment of influenza virus infections

X. Liu, B. Zhang, et al.

This groundbreaking study reveals a novel bifunctional small molecule that combines the power of the neuraminidase inhibitor zanamivir with the immunogenic hapten dinitrophenyl (DNP). The findings demonstrate its capability to not only inhibit virus release but also to activate immune responses to eliminate both free viruses and infected cells. Conducted by a team of researchers at Purdue University, this research showcases potential treatments for influenza A and B infections that are resistant to current therapies.

00:00
00:00
Playback language: English
Abstract
This study introduces a bifunctional small molecule, conjugating the neuraminidase inhibitor zanamivir with the immunogenic hapten dinitrophenyl (DNP), to simultaneously inhibit virus release and trigger immune-mediated elimination of free virus and infected cells. A single dose eradicated advanced infections in mice infected with influenza A and B viruses, even when administered up to three days post-infection, suggesting potential for treating infections unresponsive to current therapies.
Publisher
Nature Communications
Published On
Nov 05, 2020
Authors
Xin Liu, Boning Zhang, Yingcai Wang, Hanan S Haymour, Fenghua Zhang, Le-cun Xu, Madduri Srinivasarao, Philip S Low
Tags
bifunctional small molecule
neuraminidase inhibitor
zanamivir
immunogenic hapten
dinitrophenyl
influenza
virus elimination
Listen, Learn & Level Up
Over 10,000 hours of research content in 25+ fields, available in 12+ languages.
No more digging through PDFs, just hit play and absorb the world's latest research in your language, on your time.
listen to research audio papers with researchbunny